BioGaia conducts research and development to provide consumers with clinically proven, health-promoting, patented and user-friendly probiotic products.
”Clinically Proven Probiotics”. Dietary supplements containing scientifically tested probiotics of a high quality that are sold in pharmacies and similar sales outlets. In most markets, the products are recommended by doctors or other healthcare professionals.
BioGaia’s vision is to be a ground-breaking leader in probiotics. BioGaia’s strategy rests on five cornerstones: Growth, Customer Focus, Operational Excellence, Innovation and Sustainability. It is based on the following:
- Conducting high quality clinical studies.
- Developing innovative new products and packaging solutions.
- Providing our partners with effective support, among other things by participating in international medical conferences, hosting seminars, training sales staff and providing marketing materials based on clinical studies.
- Having dedicated and skilled employees who challenge the existing solutions.
BioGaia’s Class B share
is listed on the Mid Cap list of Nasdaq Stockholm.
in 1990 by Peter Rothschild and Jan Annwall.